Updated: Feb 15, 2022
We have exciting news to share. The Bonnie J. Addario Lung Cancer Foundation (ALCF) has proudly joined forces with the Lung Cancer Alliance (LCA) to form a new powerhouse organization called the GO2 Foundation for Lung Cancer.
Together, the GO2 Foundation becomes the "go-to" local and global source serving and advocating for the needs of the entire lung cancer community — those at risk, diagnosed, vulnerable, and all others impacted by the disease. The GO2 Foundation will be the place where everyone impacted by lung cancer can find personalized care, powerful connections, and purposeful collaboration.
As you know, we have been fundraising through ALCF to support two ROS1 research studies in partnership with the Addario Lung Cancer Medical Institute (ALCMI). We are happy to share that our relationship with ALCMI will not change because of this merger. ALCMI will now partner with the GO2 Foundation, but will remain a separate and independent 501c(3) non-profit organization and will continue to coordinate innovative, patient-centric lung cancer studies including those aimed at better understanding ROS1 lung cancer. Fundraising in support of these studies will now be done through the GO2 Foundation, but everything else about our partnership with both organizations remains the same.
If you have any questions about the merger or about the ROS1ders work with GO2 Foundation or ALCMI, please contact Nicole Phipps Pietras - firstname.lastname@example.org.